Breaking News, Financial News

Abbott Laboratories 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott Laboratories 3Q Revenues: $6.4 billion (+14%) 3Q Earnings: $717 million (flat) YTD Revenues: $18.7 billion (+15%) YTD Earnings: $2.4 billion (+10%) Comments: Pharma sales grew 20% to $3.5 billion in 3Q07, driven by growth in Humira, Kaletra and TriCor sales. Earnings were impaired by costs related to a buyout of Guidant’s stent business....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters